Teva, Intel to develop wearables to monitor Huntington’s disease

This post was originally published on this site

(Reuters) – Teva Pharmaceutical Industries Ltd said on Thursday it was collaborating with Intel Corp to develop a wearable device to monitor patients with Huntington’s, a fatal degenerative disease.